Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 3.07 Million USD | 45.5% |
| 2019 | 2.11 Million USD | 4.78% |
| 2018 | 2.01 Million USD | -11.5% |
| 2017 | 2.28 Million USD | -18.05% |
| 2016 | 2.78 Million USD | -34.9% |
| 2015 | 4.27 Million USD | 103023.14% |
| 2014 | -4154.02 USD | 61.96% |
| 2013 | -10.92 Thousand USD | -122.18% |
| 2012 | -4915.41 USD | 97.38% |
| 2011 | -187.47 Thousand USD | 68.38% |
| 2010 | -592.96 Thousand USD | -114.58% |
| 2009 | 4.06 Million USD | -22.63% |
| 2008 | 5.25 Million USD | 172.19% |
| 2007 | -7.28 Million USD | 2.01% |
| 2006 | -7.43 Million USD | -194.11% |
| 2005 | -2.52 Million USD | -253.88% |
| 2004 | -714.16 Thousand USD | 0.0% |
| 2002 | -499.39 USD | 24.36% |
| 2001 | -660.23 USD | -465.5% |
| 2000 | -116.75 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q4 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2021 Q1 | 3.26 Million USD | 5.94% |
| 2021 FY | - USD | -100.0% |
| 2021 Q3 | - USD | 100.0% |
| 2021 Q2 | -25.84 Thousand USD | -100.79% |
| 2020 Q2 | 2.71 Million USD | 13.42% |
| 2020 Q1 | 2.39 Million USD | 13.24% |
| 2020 Q4 | 3.07 Million USD | 2.92% |
| 2020 Q3 | 2.99 Million USD | 10.08% |
| 2020 FY | 3.07 Million USD | 45.5% |
| 2019 Q3 | 2.08 Million USD | 1.78% |
| 2019 FY | 2.11 Million USD | 4.78% |
| 2019 Q4 | 2.11 Million USD | 1.57% |
| 2019 Q2 | 2.04 Million USD | -25.67% |
| 2019 Q1 | 2.75 Million USD | 36.35% |
| 2018 Q4 | 2.01 Million USD | -35.86% |
| 2018 FY | 2.01 Million USD | -11.5% |
| 2018 Q3 | 3.14 Million USD | 30.62% |
| 2018 Q2 | 2.4 Million USD | 3.85% |
| 2018 Q1 | 2.32 Million USD | 1.73% |
| 2017 Q2 | 2.74 Million USD | -3.55% |
| 2017 Q1 | 2.84 Million USD | 2.23% |
| 2017 FY | 2.28 Million USD | -18.05% |
| 2017 Q4 | 2.28 Million USD | 0.84% |
| 2017 Q3 | 2.26 Million USD | -17.58% |
| 2016 Q1 | 3.49 Million USD | 81566.67% |
| 2016 Q4 | 2.78 Million USD | -29.14% |
| 2016 FY | 2.78 Million USD | -34.9% |
| 2016 Q3 | 3.92 Million USD | 10.66% |
| 2016 Q2 | 3.54 Million USD | 1.66% |
| 2015 Q3 | - USD | 100.0% |
| 2015 Q2 | -4717.62 USD | 31.89% |
| 2015 Q4 | 4275.45 USD | 0.0% |
| 2015 FY | 4.27 Million USD | 103023.14% |
| 2015 Q1 | -6926.76 USD | 30.58% |
| 2014 FY | -4154.02 USD | 61.96% |
| 2014 Q3 | -17.71 Thousand USD | 12.97% |
| 2014 Q1 | -10.92 Thousand USD | -533.98% |
| 2014 Q4 | -9978.68 USD | 43.66% |
| 2014 Q2 | -20.35 Thousand USD | -86.36% |
| 2013 Q2 | -4506.36 USD | 8.32% |
| 2013 Q1 | -4915.41 USD | 91.6% |
| 2013 FY | -10.92 Thousand USD | -122.18% |
| 2013 Q4 | -1722.60 USD | 3.44% |
| 2013 Q3 | -1783.95 USD | 60.41% |
| 2012 Q2 | -96.5 Thousand USD | 48.52% |
| 2012 FY | -4915.41 USD | 97.38% |
| 2012 Q3 | -43.92 Thousand USD | 54.49% |
| 2012 Q1 | -187.47 Thousand USD | 28.38% |
| 2012 Q4 | -58.51 Thousand USD | -33.24% |
| 2011 FY | -187.47 Thousand USD | 68.38% |
| 2011 Q4 | -261.75 Thousand USD | 33.36% |
| 2011 Q3 | -392.76 Thousand USD | 38.03% |
| 2011 Q1 | -592.96 Thousand USD | -513.7% |
| 2011 Q2 | -633.81 Thousand USD | -6.89% |
| 2010 Q4 | -96.62 Thousand USD | 53.82% |
| 2010 Q1 | 4.06 Million USD | 377.05% |
| 2010 Q2 | -685.4 Thousand USD | -116.85% |
| 2010 FY | -592.96 Thousand USD | -114.58% |
| 2010 Q3 | -209.21 Thousand USD | 69.48% |
| 2009 FY | 4.06 Million USD | -22.63% |
| 2009 Q1 | 5.25 Million USD | 243.23% |
| 2009 Q2 | -1.85 Million USD | -135.19% |
| 2009 Q3 | -1.77 Million USD | 4.23% |
| 2009 Q4 | -1.46 Million USD | 17.14% |
| 2008 Q2 | -4.01 Million USD | 44.88% |
| 2008 Q4 | -3.67 Million USD | -280.33% |
| 2008 FY | 5.25 Million USD | 172.19% |
| 2008 Q1 | -7.28 Million USD | 48.85% |
| 2008 Q3 | -965.26 Thousand USD | 75.95% |
| 2007 Q1 | -7.43 Million USD | 13.67% |
| 2007 Q2 | -15.31 Million USD | -106.02% |
| 2007 Q3 | -16.74 Million USD | -9.36% |
| 2007 Q4 | -14.23 Million USD | 14.97% |
| 2007 FY | -7.28 Million USD | 2.01% |
| 2006 Q3 | -609.19 Thousand USD | 43.55% |
| 2006 Q1 | -2.52 Million USD | -492087.72% |
| 2006 FY | -7.43 Million USD | -194.11% |
| 2006 Q4 | -8.61 Million USD | -1313.37% |
| 2006 Q2 | -1.07 Million USD | 57.3% |
| 2005 Q4 | -513.48 USD | 97.82% |
| 2005 Q1 | -714.16 Thousand USD | 44.1% |
| 2005 Q3 | -23.55 Thousand USD | -132.52% |
| 2005 FY | -2.52 Million USD | -253.88% |
| 2005 Q2 | 72.44 Thousand USD | 110.14% |
| 2004 Q2 | -378.11 Thousand USD | 57.66% |
| 2004 Q1 | -893.07 Thousand USD | -832.37% |
| 2004 FY | -714.16 Thousand USD | 0.0% |
| 2004 Q4 | -1.27 Million USD | -328.86% |
| 2004 Q3 | -297.88 Thousand USD | 21.22% |
| 2003 Q1 | -115.61 USD | 52.96% |
| 2003 Q4 | -95.78 Thousand USD | -55753.02% |
| 2003 Q3 | -171.49 USD | 65.66% |
| 2003 Q2 | -499.39 USD | -331.98% |
| 2002 Q3 | -303.99 USD | 53.96% |
| 2002 Q1 | -7432.25 USD | -488.98% |
| 2002 Q2 | -660.23 USD | 91.12% |
| 2002 Q4 | -245.74 USD | 19.16% |
| 2002 FY | -499.39 USD | 24.36% |
| 2001 Q4 | -1261.89 USD | -1003.97% |
| 2001 FY | -660.23 USD | -465.5% |
| 2001 Q3 | -114.30 USD | 0.0% |
| 2000 FY | -116.75 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 100.0% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 100.0% |
| Polarean Imaging plc | -5.94 Million USD | 100.0% |
| Avitar, Inc. | 5.17 Million USD | 100.0% |
| CVR Medical Corp. | - USD | NaN% |
| IR-Med Inc. | -606 Thousand USD | 100.0% |
| AVITA Medical, Inc. | -26.23 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -7000.00 USD | 100.0% |
| Össur hf. | 395.08 Million USD | 100.0% |
| Zecotek Photonics Inc. | 2.76 Million USD | 100.0% |
| QHSLab, Inc. | 1.72 Million USD | 100.0% |
| Wellstar International, Inc. | 51.36 Million USD | 100.0% |
| Össur hf. | 395.08 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 100.0% |
| Escalon Medical Corp. | 315.68 Thousand USD | 100.0% |
| Aurora Spine Corporation | 1.9 Million USD | 100.0% |
| BrainsWay Ltd. | -10.32 Million USD | 100.0% |
| NewCardio, Inc. | 2.41 Million USD | 100.0% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 100.0% |
| Vivos Inc. | -1.59 Million USD | 100.0% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.0% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 100.0% |
| REMSleep Holdings, Inc. | -540.98 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 100.0% |
| Nanomix Corporation | 11.38 Million USD | 100.0% |
| Theraclion SA | -5.86 Million EUR | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 3.98 Million USD | 100.0% |
| Positron Corporation | 1.68 Million USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 100.0% |
| Lombard Medical, Inc. | 11.49 Million USD | 100.0% |
| ALR Technologies Inc. | 19.14 Million USD | 100.0% |
| Stratec SE | 119.12 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.05 Million USD | 100.0% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 100.0% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 100.0% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | 133.52 USD | 100.0% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 100.0% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | 2.1 Million USD | 100.0% |
| United American Healthcare Corporation | -9.32 Million USD | 100.0% |
| ECGI Holdings, Inc. | 3.17 Million USD | 100.0% |
| Capital Group Holdings, Inc. | -3508.00 USD | 100.0% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 100.0% |
| Urologix, Inc. | 4.61 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 100.0% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 100.0% |
| SS Innovations International, Inc. | 1.18 Million USD | 100.0% |
| Qualis Innovations, Inc. | 6671.00 USD | 100.0% |
| Smith & Nephew plc | 2.77 Billion USD | 100.0% |
| NIOX Group Plc | -23.93 Million USD | 100.0% |
| Fuse Medical, Inc. | 1.75 Million USD | 100.0% |
| Broncus Holding Corporation | -81.42 Million USD | 100.0% |
| Brain Scientific Inc. | 2.11 Million USD | 100.0% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 100.0% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 100.0% |